Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during ontogeny of the murine heart

M. K. Haddox, J. R. Womble, Douglas F Larson, W. R. Roeske, D. H. Russell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Fluctuations in the activity of fetal mouse heart ornithine decarboxylase (ODC) are positively correlated to growth rate. ODC activity was maximal (27 pmoles/min/mg of protein) at 13 days of embryogenesis, the earliest time that hearts could be dissected. Stimulation of fetal cardiac ODC activity was used as an index of cardiac responsiveness to adrenergic stimulation. The ability of either maternally injected or fetally injected isoproterenol to stimulate an increase in fetal heart ODC activity in embryos close to term was concentration-dependent. The beta-adrenergic stimulant, 10 mg/kg maternally or 2 mg/kg fetally, promoted a maximal response (300-400%). Maternal injections were used routinely, therefore, for ease of experimentation. The development of the fetal heart trophic response to beta-receptor agonists was examined after maternal injections of 2 or 10 mg/kg of isoproterenol from 13 to 21 days of gestation. Isoproterenol promoted an increase in myocardial ODC activity at all times monitored during fetal development. The highest drug-stimulated activity, 57 pmoles/min/mg of protein, occurred at 16-17 days of gestation. After this, the absolute specific enzyme activity achieved after isoproterenol declined, although the magnitude of the response remained at 2.5- to 3-fold above control until birth. The stimulation was blocked by propranolol (10 mg/kg s.c.). The maximal in vivo coupling of the beta-receptor to murine ODC activity, apparent from Day 13 of gestation, precedes the development of its in vitro coupling to the chronotropic response, first apparent after 17 days.

Original languageEnglish (US)
Pages (from-to)382-386
Number of pages5
JournalMolecular Pharmacology
Volume20
Issue number2
StatePublished - 1981

Fingerprint

Ornithine Decarboxylase
Isoproterenol
Propranolol
Fetal Heart
Pregnancy
Adrenergic Agents
Mothers
Injections
Fetal Development
Contraception
Embryonic Development
Proteins
Embryonic Structures
Enzymes
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during ontogeny of the murine heart. / Haddox, M. K.; Womble, J. R.; Larson, Douglas F; Roeske, W. R.; Russell, D. H.

In: Molecular Pharmacology, Vol. 20, No. 2, 1981, p. 382-386.

Research output: Contribution to journalArticle

@article{a9d5e4476f38438695f51323be8bcbdd,
title = "Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during ontogeny of the murine heart",
abstract = "Fluctuations in the activity of fetal mouse heart ornithine decarboxylase (ODC) are positively correlated to growth rate. ODC activity was maximal (27 pmoles/min/mg of protein) at 13 days of embryogenesis, the earliest time that hearts could be dissected. Stimulation of fetal cardiac ODC activity was used as an index of cardiac responsiveness to adrenergic stimulation. The ability of either maternally injected or fetally injected isoproterenol to stimulate an increase in fetal heart ODC activity in embryos close to term was concentration-dependent. The beta-adrenergic stimulant, 10 mg/kg maternally or 2 mg/kg fetally, promoted a maximal response (300-400{\%}). Maternal injections were used routinely, therefore, for ease of experimentation. The development of the fetal heart trophic response to beta-receptor agonists was examined after maternal injections of 2 or 10 mg/kg of isoproterenol from 13 to 21 days of gestation. Isoproterenol promoted an increase in myocardial ODC activity at all times monitored during fetal development. The highest drug-stimulated activity, 57 pmoles/min/mg of protein, occurred at 16-17 days of gestation. After this, the absolute specific enzyme activity achieved after isoproterenol declined, although the magnitude of the response remained at 2.5- to 3-fold above control until birth. The stimulation was blocked by propranolol (10 mg/kg s.c.). The maximal in vivo coupling of the beta-receptor to murine ODC activity, apparent from Day 13 of gestation, precedes the development of its in vitro coupling to the chronotropic response, first apparent after 17 days.",
author = "Haddox, {M. K.} and Womble, {J. R.} and Larson, {Douglas F} and Roeske, {W. R.} and Russell, {D. H.}",
year = "1981",
language = "English (US)",
volume = "20",
pages = "382--386",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during ontogeny of the murine heart

AU - Haddox, M. K.

AU - Womble, J. R.

AU - Larson, Douglas F

AU - Roeske, W. R.

AU - Russell, D. H.

PY - 1981

Y1 - 1981

N2 - Fluctuations in the activity of fetal mouse heart ornithine decarboxylase (ODC) are positively correlated to growth rate. ODC activity was maximal (27 pmoles/min/mg of protein) at 13 days of embryogenesis, the earliest time that hearts could be dissected. Stimulation of fetal cardiac ODC activity was used as an index of cardiac responsiveness to adrenergic stimulation. The ability of either maternally injected or fetally injected isoproterenol to stimulate an increase in fetal heart ODC activity in embryos close to term was concentration-dependent. The beta-adrenergic stimulant, 10 mg/kg maternally or 2 mg/kg fetally, promoted a maximal response (300-400%). Maternal injections were used routinely, therefore, for ease of experimentation. The development of the fetal heart trophic response to beta-receptor agonists was examined after maternal injections of 2 or 10 mg/kg of isoproterenol from 13 to 21 days of gestation. Isoproterenol promoted an increase in myocardial ODC activity at all times monitored during fetal development. The highest drug-stimulated activity, 57 pmoles/min/mg of protein, occurred at 16-17 days of gestation. After this, the absolute specific enzyme activity achieved after isoproterenol declined, although the magnitude of the response remained at 2.5- to 3-fold above control until birth. The stimulation was blocked by propranolol (10 mg/kg s.c.). The maximal in vivo coupling of the beta-receptor to murine ODC activity, apparent from Day 13 of gestation, precedes the development of its in vitro coupling to the chronotropic response, first apparent after 17 days.

AB - Fluctuations in the activity of fetal mouse heart ornithine decarboxylase (ODC) are positively correlated to growth rate. ODC activity was maximal (27 pmoles/min/mg of protein) at 13 days of embryogenesis, the earliest time that hearts could be dissected. Stimulation of fetal cardiac ODC activity was used as an index of cardiac responsiveness to adrenergic stimulation. The ability of either maternally injected or fetally injected isoproterenol to stimulate an increase in fetal heart ODC activity in embryos close to term was concentration-dependent. The beta-adrenergic stimulant, 10 mg/kg maternally or 2 mg/kg fetally, promoted a maximal response (300-400%). Maternal injections were used routinely, therefore, for ease of experimentation. The development of the fetal heart trophic response to beta-receptor agonists was examined after maternal injections of 2 or 10 mg/kg of isoproterenol from 13 to 21 days of gestation. Isoproterenol promoted an increase in myocardial ODC activity at all times monitored during fetal development. The highest drug-stimulated activity, 57 pmoles/min/mg of protein, occurred at 16-17 days of gestation. After this, the absolute specific enzyme activity achieved after isoproterenol declined, although the magnitude of the response remained at 2.5- to 3-fold above control until birth. The stimulation was blocked by propranolol (10 mg/kg s.c.). The maximal in vivo coupling of the beta-receptor to murine ODC activity, apparent from Day 13 of gestation, precedes the development of its in vitro coupling to the chronotropic response, first apparent after 17 days.

UR - http://www.scopus.com/inward/record.url?scp=0019416356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019416356&partnerID=8YFLogxK

M3 - Article

C2 - 7300819

AN - SCOPUS:0019416356

VL - 20

SP - 382

EP - 386

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -